Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic options in a patient with MELAS and diabetes mellitus: follow-up after 6 months of treatment

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 05 June 2019

A Letter to the Editor to this article was published on 05 June 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yatsuga S et al (2012) MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta 1820(5):619–624

    Article  CAS  Google Scholar 

  2. Divakaruni SA et al (2013) Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc Natl Acad Sci USA 110(14):5422–7

    Article  CAS  Google Scholar 

  3. El-Hattab AW et al (2014) Glucose metabolism derangements in adults with the MELAS m.3243A > G mutation. Mitochondrion 18:63–69

    Article  CAS  Google Scholar 

  4. Maedler K et al (2005) Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 90:501–506

    Article  CAS  Google Scholar 

  5. Artuso R et al (2015 Feb) Therapeutic implications of novel mutations of the RFX6 gene associated with early-onset diabetes. Pharmacogenomics J 15(1):49–54

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetology, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Florence, Italy

    C. Cosentino, E. Mannucci & B. Cresci

  2. Department of Neurosciences, Drug Research, and Child’s Health, University of Florence, Florence, Italy

    M. Contento

  3. Division Neurology 2, Careggi University Hospital, University of Florence, Florence, Italy

    M. Paganini

Authors
  1. C. Cosentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Contento
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Paganini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Mannucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Cresci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Cosentino.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient included in the study.

Additional information

Managed by Massimo Federici.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cosentino, C., Contento, M., Paganini, M. et al. Therapeutic options in a patient with MELAS and diabetes mellitus: follow-up after 6 months of treatment. Acta Diabetol 56, 1231–1233 (2019). https://doi.org/10.1007/s00592-019-01302-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-019-01302-z

Keywords

Search

Navigation